Crossmark

Incorporation of in-vitro, in-vivo, and in-silico antidiabetic activity of a bioactive compound extracted from the red macroalgae Gracilaria corticata

Crossref DOI link: https://doi.org/10.1007/s11756-025-02128-7

Published Online: 2026-01-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ilakkiya, Vijayakumar

Dhanalakshmi, Balasubramanian

Divya, Mani

Kaviya, Vijayakumar

Shilpa, Sivan

Manikandakrishnan, Muthushanmugam

Bharathidasan, Veeraiyan

Sarathy, Palanivel Partha https://orcid.org/0000-0003-2282-4652
License Information

Text and Data Mining valid from 2026-01-26

Version of Record valid from 2026-01-26
More Information

Article History

Received: 27 December 2023

Accepted: 14 October 2025

First Online: 26 January 2026

Declarations

:

: This article does not contain any studies with human participants, although sampling, care, and experimental use of animals were followed by adopting the National Guidelines.

: The authors declare that they have no conflicts of interest.

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Document is current

Any future updates will be listed below